Track somatorelin in Peptimes™
Somatorelin is the synthetic form of human growth hormone-releasing hormone (GHRH), a peptide of 44 amino acids with an amide end: GHRH(1-44)-NH2. FDA's substance registry also lists it as somatoliberin and GRF 1-44. (Source: FDA's substance registry (GSRS).)
Is somatorelin FDA-approved?
No. Somatorelin isn't FDA-approved, and Drugs@FDA lists no application with it as an active ingredient.
Somatorelin
Also: GHRH(1-44)-NH2, GRF 1-44, somatoliberin, growth hormone-releasing hormone, 1-44 human amide
- Status label in the Peptimes Library
- Not FDA-Approved
- Routes in Peptimes
- SubcutaneousOther
- Updated
- 1 Nov 2026
US regulatory status
How to track it in Peptimes
Add somatorelin in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Not FDA-Approved”.
- Routes: subcutaneous or Other. Choose the one that matches each dose.
- Logging: the amount you took, the route and how you feel.
- Injection sites: subcutaneous doses record the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next. Other doses skip this step.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell somatorelin or any other compound.
More sources
- FDA, Global Substance Registration System, Somatorelin, checked 1 Nov 2026: its sequence of 44 amino acids, and the names GHRH(1-44)-NH2, GRF 1-44 and somatoliberin.
- FDA, Drugs@FDA, checked 1 Nov 2026 through FDA’s openFDA Drugs@FDA data: no application lists somatorelin as an active ingredient.